monitor
oseltamivirresist
infl
uenza
virus
orv
neuraminidas
na
japan
infl
uenza
season
analyz
clinic
sampl
na
sequenc
andor
na
inhibit
assay
total
frequenc
orv
season
season
indic
mark
increas
orv
japan
infl
uenza
season
na
gene
orv
season
fell
distinct
lineag
substitut
wherea
orv
season
fell
lineag
na
inhibit
assay
sequenc
show
almost
orv
sensit
zanamivir
amantadin
hemagglutin
inhibit
test
show
orv
antigenet
similar
vaccin
strain
data
indic
current
vaccin
zanamivir
amantadin
effect
recent
orv
continu
surveil
remain
necessari
nfl
uenza
b
virus
major
pathogen
repres
threat
public
health
subsequ
econom
loss
worldwid
vaccin
primari
method
prevent
antivir
drug
use
mainli
prophylaxi
therapi
current
class
drug
matrix
blocker
neuraminidas
inhibitor
nai
avail
blocker
amantadin
rimantadin
commonli
use
rapid
gener
resist
lack
effi
caci
infl
uenza
b
viru
nai
zanamivir
oseltamivir
wide
use
effect
infl
uenza
b
virus
low
frequenc
resist
nai
viru
surveil
studi
sever
group
demonstr
virus
test
show
natur
occur
resist
oseltamivir
indic
limit
humantohuman
transmiss
virus
begin
infl
uenza
season
howev
detect
substanti
increas
number
oseltamivirresist
infl
uenza
virus
orv
report
mainli
countri
europ
preval
vari
highest
level
norway
franc
virus
show
specifi
c
na
mutat
histidinetotyrosin
substitut
aa
posit
number
confer
highlevel
resist
oseltamivir
orv
isol
naiuntreat
patient
retain
similar
abil
humantohuman
transmiss
oseltamivirsensit
infl
uenza
virus
osv
respons
public
health
concern
orv
world
health
organ
direct
global
infl
uenza
surveil
network
laboratori
intensifi
nai
surveil
announc
regularli
updat
summari
orv
data
collect
laboratori
websit
site
report
global
frequenc
increas
octob
april
octob
indic
orv
spread
rapidli
around
world
japan
highest
annual
level
oseltamivir
usag
per
capita
world
compris
world
consumpt
high
use
oseltamivir
rais
concern
emerg
osv
increas
resist
drug
moreov
japan
recent
infl
uenza
season
domin
infl
uenza
virus
figur
high
preval
orv
observ
primari
select
oseltamivir
treatment
infl
uenza
patient
reconsid
thu
monitor
orv
seriou
public
health
issu
estim
frequenc
orv
character
virus
analyz
clinic
sampl
isol
season
isol
season
na
sequenc
andor
nai
inhibit
assay
total
frequenc
season
season
indic
orv
increas
dramat
japan
phylogenet
tree
na
gene
construct
neighborjoin
method
phylogenet
tree
describ
repres
orv
osv
isol
sever
prefectur
japan
sequenc
inform
isol
countri
obtain
global
initi
share
avian
infl
uenza
data
lo
alamo
nation
laboratori
databas
amino
acid
posit
phylogenet
tree
describ
number
chemiluminesc
na
inhibit
assay
peremerg
infecti
diseas
wwwcdcgoveid
vol
form
use
na
star
kit
appli
biosystem
tokyo
japan
slight
modifi
cation
instruct
provid
manufactur
fi
nal
drug
concentr
rang
nmoll
nmoll
oseltamivir
nmoll
nmoll
zanamivir
chemiluminesc
light
emiss
measur
use
plate
reader
berthhold
technolog
bad
wildbad
germani
drug
concentr
requir
inhibit
na
activ
ic
calcul
method
use
mikrowin
version
softwar
mikrotek
laborsystem
gmbh
overath
germani
hi
test
perform
evalu
reactiv
ferret
antiserum
vaccin
strain
describ
manual
antiserum
treat
receptordestroy
enzym
ii
denka
seiken
tokyo
japan
adsorb
pack
turkey
erythrocyt
test
prevent
nonspecifi
c
reaction
suspens
turkey
erythrocyt
use
hi
test
virus
reduc
hi
titer
homolog
titer
antiserum
regard
antigen
variant
determin
cutoff
valu
nairesist
outlier
sensit
virus
boxandwhisk
plot
use
cutoff
valu
defi
ned
upper
quartil
rang
percentil
studi
orv
exclud
overal
popul
statist
analysi
outlier
exclud
calcul
mean
valu
standard
deviat
ic
estim
frequenc
infl
uenza
orv
prefectur
japan
isol
season
isol
season
collect
prefectur
examin
na
sequenc
detect
mutat
na
protein
season
virus
possess
mutat
total
frequenc
orv
figur
panel
observ
prefectur
indic
frequenc
orv
signifi
cantli
lower
countri
europ
unit
state
tottori
prefectur
howev
infl
uenza
virus
test
possess
show
markedli
higher
frequenc
prefectur
season
howev
orv
observ
nationwid
infl
uenza
virus
virus
possess
mutat
total
frequenc
figur
orv
also
genet
close
osv
japan
onlin
appendix
figur
ha
gene
also
genet
ident
close
togeth
onlin
appendix
figur
suggest
almost
orv
japan
hawaii
lineag
deriv
osv
japan
hand
northerneu
lineag
osv
counterpart
observ
foreign
orv
genet
close
orv
japan
observ
season
na
gene
orv
japan
close
orv
isol
countri
europ
ie
season
orv
japan
share
ha
protein
divid
subclad
common
amino
acid
chang
ha
andor
na
onlin
appendix
figur
orv
japan
genet
close
orv
isol
north
america
hawaii
eg
wherea
orv
repres
infl
uenza
virus
season
japan
orv
close
orv
isol
south
africa
australia
southern
hemispher
eg
orv
except
isol
emerg
orv
japan
subclad
fi
nding
suggest
orv
japan
within
northerneu
lineag
would
emerg
domest
instead
may
introduc
variou
countri
virus
isol
season
isol
season
test
na
inhibit
assay
possess
substitut
na
inhibit
assay
although
precis
ic
valu
calcul
normal
sigmoid
curv
figur
panel
b
virus
gener
type
unusu
sigmoid
curv
figur
panel
c
result
mix
popul
nairesist
sensit
virus
previous
report
tent
ic
valu
calcul
type
curv
figur
panel
c
includ
overal
statist
analysi
valu
could
calcul
type
b
curv
figur
panel
later
virus
regard
resist
candid
na
inhibit
assay
oseltamivir
osv
show
mean
ic
sd
nmoll
rang
nmoll
orv
mean
sd
ic
nmoll
rang
nmoll
show
reduct
suscept
oseltamivir
one
osv
identifi
ed
statist
outlier
cutoff
ic
nmoll
upper
quartil
interquartil
rang
show
substitut
na
protein
tabl
na
inhibit
assay
zanamivir
statist
analysi
show
virus
regard
zanamivirsensit
virus
mean
sd
ic
nmoll
rang
nmoll
virus
orv
osv
identifi
ed
outlier
cutoff
ic
nmoll
tabl
tabl
data
suggest
chang
substanti
effect
sensit
zanamivir
oseltamivir
moreov
substitut
confer
highlevel
resist
nai
figur
panel
b
howev
recent
studi
report
chang
detect
viru
propag
cell
cultur
origin
clinic
specimen
tottori
prefectur
locat
western
part
main
island
japan
compris
citi
geograph
divid
area
prefectur
lowest
popul
japan
figur
panel
b
despit
low
frequenc
japan
season
unexpectedli
high
frequenc
orv
observ
tottori
prefectur
figur
panel
orv
tottori
collect
citi
area
systemat
bia
appar
sampl
process
figur
panel
b
phylogenet
analysi
na
gene
show
orv
form
subclad
figur
orv
observ
suggest
orv
would
deriv
osv
tottori
prefectur
map
studi
orv
show
orv
hawaii
lineag
collect
tottori
citi
primarili
end
januari
wherea
orv
northerneu
lineag
collect
citi
includ
tottori
citi
februari
march
genet
divers
orv
belong
cocircul
tottori
citi
eastern
area
figur
panel
b
tottori
case
rais
concern
possibl
tottori
orv
could
surviv
becom
origin
orv
season
japan
howev
phylogenet
analysi
show
orv
isol
season
genet
close
orv
tottori
onlin
appendix
figur
result
orv
tottori
seem
elimin
season
orv
may
introduc
counti
circul
japan
studi
demonstr
orv
dramat
increas
japan
season
season
test
orv
show
reduct
suscept
oseltamivir
na
inhibit
assay
hand
almost
orv
remain
sensit
antiviraldrug
eg
zanamivir
inhibitor
hi
test
suggest
current
vaccin
would
effect
recent
orv
addit
recent
studi
report
symptom
hospit
rate
patient
infect
orv
differ
seen
osv
figur
panel
c
type
type
b
although
virus
tend
gener
pattern
repeat
test
sampl
type
b
select
case
show
mix
popul
tend
show
normal
curv
fit
figur
panel
b
ic
valu
virus
tend
higher
mean
ic
valu
exceed
cutoff
valu
japan
largest
per
capita
use
oseltamivir
world
use
could
caus
effi
cient
select
orv
individu
patient
japan
might
initi
site
worldwid
spread
orv
howev
longterm
nai
surveil
japan
recent
surveil
show
low
frequenc
nairesist
virus
strain
subtyp
suggest
transmiss
orv
select
drug
pressur
remark
decreas
addit
previou
nai
surveil
sever
anim
studi
also
suggest
nairesist
virus
would
becom
defect
virus
attenu
infect
transmiss
human
contrast
despit
littl
nai
use
high
emerg
orv
detect
sever
countri
europ
sinc
novemb
orv
effi
cient
transmiss
osv
humantohuman
transmiss
result
worldwid
spread
short
period
time
although
whether
initi
orv
detect
norway
season
appear
nai
drug
pressur
unknown
orv
may
obtain
amino
acid
chang
na
andor
protein
compens
defect
addit
substitut
na
protein
orv
belong
genet
northerneu
lineag
clade
suggest
gene
constel
may
contain
big
advantag
retain
infect
transmiss
interest
question
aros
orv
japan
origin
hawaii
lineag
almost
orv
japan
would
deriv
osv
japan
na
gene
orv
similar
osv
counterpart
isol
similar
time
similar
region
onlin
appendix
figur
hand
northerneu
lineag
orv
japan
would
introduc
countri
almost
orv
would
import
countri
europ
orv
compris
isol
orv
genet
similar
orv
isol
southern
hemispher
infl
uenza
activ
southern
hemispher
occur
half
year
earlier
northern
hemispher
orv
japan
conceiv
could
import
southern
hemispher
orv
genet
similar
orv
isol
north
america
hawaii
collect
month
orv
similar
suggest
orv
might
deriv
unknown
common
origin
orv
orv
obtain
genet
similar
orv
isol
tottori
indic
orv
tottori
elimin
form
origin
orv
season
japan
belong
clade
patient
viru
isol
known
taken
oseltamivir
sampl
indic
select
drug
pressur
person
might
select
orv
na
inhibit
assay
zanamivir
virus
includ
orv
osv
show
reduc
sensit
zanamivir
na
sequenc
virus
show
type
amino
acid
chang
one
viru
osv
possess
substitut
reportedli
confer
resist
zanamivir
convers
virus
possess
gvn
amino
acid
chang
n
e
among
subtyp
virus
g
e
n
v
among
report
virus
substitut
often
exhibit
reduc
sensit
nai
howev
recent
studi
report
possibl
role
cell
cultur
select
variant
virus
present
studi
variat
also
detect
avail
origin
clinic
specimen
tabl
support
previou
fi
nding
thu
conclud
virus
variat
would
emerg
natur
orv
would
remain
sensit
zanamivir
sequenc
gene
confi
rmed
almost
japanes
orv
belong
clade
retain
sensit
genotyp
inhibitor
consist
previous
report
recent
clade
virus
sensit
inhibitor
clade
virus
resist
season
also
address
nai
surveil
type
b
circul
japan
identifi
ed
virus
resist
nai
convers
march
earli
april
new
swineorigin
infl
uenza
viru
known
pandem
viru
emerg
mexico
unit
state
spread
rapidli
mani
countri
includ
japan
june
detect
pandem
viru
na
protein
report
denmark
hong
kong
special
administr
region
peopl
republ
china
japan
orv
pandem
viru
emerg
sporad
case
evid
effi
cient
humantohuman
transmiss
although
oseltamivir
remain
valuabl
drug
treatment
pandem
mani
orv
isol
prophylaxi
half
dose
drug
therefor
prophylaxi
oseltamivir
may
recommend
